Literature DB >> 15213169

Transcriptional responses of intestinal epithelial cells to infection with Vibrio cholerae.

Neil R Stokes1, Xin Zhou, Stephen J Meltzer, James B Kaper.   

Abstract

Vibrio cholerae is a noninvasive enteric bacterium that causes the severe diarrheal disease cholera. Candidate cholera vaccines have been engineered by deleting genes encoding known virulence factors in V. cholerae; however, many of these attenuated strains were still reactogenic in human volunteers. In this study, DNA arrays were utilized to monitor the transcriptional responses of human intestinal epithelial cells (T84) to eight strains of V. cholerae, including attenuated, toxigenic, and environmental isolates. cDNA probes generated from host RNA samples were hybridized against low- and high-density gene arrays. V. cholerae induced the transcription of a variety of host genes and repressed the expression of a lower number of genes. Expression patterns were confirmed for certain genes by reverse transcriptase PCR and enzyme-linked immunosorbent assays. A core subset of genes was found to be differentially regulated in all experiments. These genes included genes involved in innate mucosal immunity, intracellular signaling, and cellular proliferation. Reactogenic vaccine strains induced greater expression of genes for certain proinflammatory cytokines than nonreactogenic strains. Wild-type and attenuated derivatives induced and repressed many genes in common, although there were differences in the transcription profiles. These results indicate that the types of host genes modulated by attenuated V. cholerae, and the extent of their induction, may mediate the symptoms seen with reactogenic cholera vaccine strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213169      PMCID: PMC427408          DOI: 10.1128/IAI.72.7.4240-4248.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  53 in total

1.  Identification and characterization of a novel monocyte/macrophage differentiation-dependent gene that is responsive to lipopolysaccharide, ceramide, and lysophosphatidylcholine.

Authors:  A Pietzsch; C Büchler; C Aslanidis; G Schmitz
Journal:  Biochem Biophys Res Commun       Date:  1997-06-09       Impact factor: 3.575

2.  Motility mutants of Vibrio cholerae O1 have reduced adherence in vitro to human small intestinal epithelial cells as demonstrated by ELISA.

Authors:  T Postnova; O G Gómez-Duarte; K Richardson
Journal:  Microbiology       Date:  1996-10       Impact factor: 2.777

Review 3.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression.

Authors:  C L Gardel; J J Mekalanos
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae.

Authors:  T M Silva; M A Schleupner; C O Tacket; T S Steiner; J B Kaper; R Edelman; R Guerrant
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.

Authors:  J Michalski; J E Galen; A Fasano; J B Kaper
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype.

Authors:  T S Coster; K P Killeen; M K Waldor; D T Beattie; D R Spriggs; J R Kenner; A Trofa; J C Sadoff; J J Mekalanos; D N Taylor
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

8.  Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge.

Authors:  C O Tacket; G Losonsky; J P Nataro; L Comstock; J Michalski; R Edelman; J B Kaper; M M Levine
Journal:  J Infect Dis       Date:  1995-09       Impact factor: 5.226

9.  Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.

Authors:  C O Tacket; G Losonsky; J P Nataro; S J Cryz; R Edelman; A Fasano; J Michalski; J B Kaper; M M Levine
Journal:  J Infect Dis       Date:  1993-12       Impact factor: 5.226

10.  Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1.

Authors:  J R Kenner; T S Coster; D N Taylor; A F Trofa; M Barrera-Oro; T Hyman; J M Adams; D T Beattie; K P Killeen; D R Spriggs
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  3 in total

1.  Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.

Authors:  Anne L Bishop; Bharathi Patimalla; Andrew Camilli
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

2.  Probiotic bacteria change Escherichia coli-induced gene expression in cultured colonocytes: Implications in intestinal pathophysiology.

Authors:  Pinaki Panigrahi; Gheorghe T Braileanu; Hegang Chen; O Colin Stine
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

3.  Cholera host response gene networks: preliminary studies.

Authors:  Paul Shapshak; Charurut Somboonwit; Shu Cao; John T Sinnott
Journal:  Bioinformation       Date:  2017-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.